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Processing of the nonstructural polyprotein of the hepatitis C virus (HCV) requires the serine-type proteinase located in
the amino-terminal domain of NS3. To identify residues within NS3 determining substrate specificity, a mutation analysis
was performed. Using sequence alignments and three-dimensional structure predictions, amino acids assumed to be
important for specificity were replaced and the enzymes were tested in an intracellular trans-processing assay for their
effects on cleavage of an NS4B-5B substrate. For some of the substitutions at positions 133, 134, 135, 136, 138, 152, 155,
157, and 169, slightly reduced processing efficiencies were observed but in no case was the substrate specificity altered.
In contrast, substitutions of the phenylalanine at position 154 resulted in a modified cleavage pattern, suggesting an important
role for this residue in substrate specificity. To substantiate this assumption, a panel of NS4B-5B substrates carrying
different P1 residues at the NS4B/5A site were tested for cleavage by these altered proteinases. We found that substitution
of Phe-154 by alanine, by valine, and particularly by threonine generated enzymes with the following affinities for aliphatic
P1 residues: C  L  I  V for 154 F r A, C  L  I  V for 154 F r V and L  C  I  V for 154 F r T. Neither leucine
nor isoleucine nor valine was accepted by the parental NS3 proteinase, showing that Phe-154 is an important determinant
for substrate specificity. Furthermore, we present evidence that Ala-157 plays an additional but minor role for this property.
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INTRODUCTION capsid (Hsu et al., 1993; Santolini et al., 1994; Matsumoto
et al., 1996). E1 and E2 are the viral envelope glycopro-
The hepatitis C virus (HCV) is one of the major causes teins (Matsuura et al., 1992, Spaete et al., 1992; Ralston
of transfusion-associated hepatitis worldwide. Most, if et al., 1993; Dubuisson et al., 1994). Nonstructural protein
not all, infections become chronic and result in various (NS) 2 most likely encodes the enzymatically active do-
clinic outcomes, including acute hepatitis, chronic hepa- main of the NS2-3 proteinase (Grakoui et al., 1993a; Hiji-
titis, and liver cirrhosis. Chronic HCV infections, in partic- kata et al., 1993). NS3 is a bifunctional molecule with the
ular those with cirrhosis, are also associated with the amino-terminal domain carrying a serine-type proteinase
development of hepatocellular carcinoma (for reviews (Bartenschlager et al., 1993; Eckart et al., 1993; Grakoui
see Cuthbert, 1994; Houghton, 1996). No effective ther- et al., 1993b; Hijikata et al., 1993; Tomei et al., 1993) and
apy nor any vaccine is yet available. the carboxy-terminal domain a nucleoside triphospha-
The hepatitis C virus is classified together with the tase/RNA helicase activity (Suzich et al., 1993; Kim et al.,
flaviviruses and the animal-pathogenic pestiviruses in 1995). NS4A is an NS3 proteinase cofactor (Bar-
the family Flaviviridae (Murphy et al., 1995). These vi- tenschlager et al., 1994; Failla et al., 1994; Lin et al., 1994;
ruses have in common a single-stranded RNA genome Tanji et al., 1995) and NS5B was shown to be an RNA-
of positive polarity, which in the case of HCV has a length dependent RNA polymerase (Behrens et al., 1996; Loh-
of about 9600 nucleotides. It carries a single long open mann et al., 1997). No functions have yet been ascribed
reading frame, encoding a 3010- to 3033-amino-acid-long to NS4B and NS5A.
polyprotein (for reviews see Rice, 1996; Bartenschlager, Proteolytic processing of the viral polyprotein is medi-
1997). It is cleaved co- and posttranslationally into at ated by two classes of proteinases: the host cell signal
least 10 mature viral proteins, which are arranged within peptidases cleaving the C-NS2 region and two viral en-
the polyprotein as follows (from the amino to the carboxy zymes responsible for processing of the remainder.
terminus): H2N-C-E1-E2-p7-NS2-NS3-NS4A-NS4B-NS5A- These are the NS2-3 proteinase, a zinc-dependent metal-
NS5B-COOH (for reviews see Rice, 1996; Bartenschlager, loproteinase cleaving at the NS2-3 junction (Grakoui et
1997). For several of these proteins, distinct functions al., 1993a; Hijikata et al., 1993), and the NS3 proteinase
can be ascribed. The core protein (C), a basic RNA-bind- located in the amino-terminal 181 residues of the NS3
ing molecule, most likely is the major constituent of the protein, which is responsible for processing at all other
sites in the NS region (Bartenschlager et al., 1993; Eckart
et al., 1993; Grakoui et al., 1993b; Hijikata et al., 1993;1 To whom correspondence and reprint requests should be ad-
Tomei et al., 1993). The scissile bond at the NS3/4Adressed. Fax: 0049-6131-395604. E-mail: bartnsch@mzdmza.zdv.uni-
mainz.de. junction is cleaved most likely by an intramolecular (cis)
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reaction, whereas processing at the NS4A/4B, NS4B/5A, we have used an intensive mutation analysis. Several
amino acid substitutions were introduced at these posi-and NS5A/5B sites can be mediated in trans (Tomei et
al., 1993; Bartenschlager et al., 1994; Failla et al., 1994; tions and the substrate specificities of the proteinases
were determined in an intracellular trans-cleavage assayLin et al., 1994). Cleavage activity of the NS3 proteinase
is greatly enhanced by the NS4A cofactor. Both proteins using NS4B-5B substrates carrying various P1 residues
at the NS4B/5A site. We found that among the singleform a stable complex, for which the amino-terminal 22
residues of NS3 and the central NS4A region are re- substitutions, only those affecting Phe-154 substantially
broadened specificity whereas those of Leu-135 and Ala-quired (Bartenschlager et al., 1995b; Failla et al., 1995;
Lin et al., 1995; Satoh et al., 1995; Kim et al., 1996). Al- 157 had no effect. However, substitutions of Ala-157 con-
tributed to an alteration of specificity when combinedthough this association is essential for cleavage at the
NS3/4A, NS4A/4B, and NS4B/5A sites, processing be- with exchanges of Phe-154.
tween NS5A and NS5B can be mediated by the NS3
proteinase in the absence of NS4A, albeit with a low MATERIALS AND METHODS
efficiency (Bartenschlager et al., 1994; Failla et al., 1994;
Cells and virusesLin et al., 1994).
The substrate requirements of the NS3 proteinase
BHK-21 and human TK0 143 cell monolayers werehave been studied intensively. A consensus sequence
grown in Dulbecco’s modified minimal essential mediumcould be deduced from sequence alignments of the four
(DMEM) supplemented with 2 mM L-glutamine, nones-cleavage sites within the polyprotein (Grakoui et al.,
sential amino acids, 100 U penicillin per milliliter, 100 mg1993b; Pizzi et al., 1994). It reads Asp/Glu-X-X-X-X-Cys/
streptomycin per milliliter, and 10% fetal calf serum (FCS).Thr f Ser/Ala, where X represents any amino acid. While
vTF7-3, a recombinant vaccinia virus expressing the RNAa cysteine residue is present at all P1 positions of trans-
polymerase of the T7 bacteriophage was described bycleavage sites, a threonine residue is found at the NS3/
Fuerst et al. (1986). Virus stocks were grown in TK0 1434A cis-cleavage site (amino acids extending from the
cell monolayers. Virus titers were measured by plaquecleaved bond toward the amino terminus are denoted
assay on the same cell line.P1, P2, P3, etc., and those extending toward the carboxy
terminus are designated P1*, P2*, P3*, etc.; Schechter
Antiseraand Berger, 1967). Using site-directed mutagenesis ex-
periments, it was shown that the P1 residue is most Monospecific antisera directed against NS3 (amino
sensitive to mutations and is therefore a major determi- acids 1007–1246), NS5A (amino acids 2102–2235), and
nant of specificity within the substrate whereas the con- NS5B (amino acids 2421–2626) have been described
served P6 and P1* residues play only a minor role (Kolyk- recently (Bartenschlager et al., 1994, 1995b). The mono-
halov et al., 1994; Komoda et al., 1994; Leinbach et al., clonal antibody directed against the hemagglutinin (HA)
1994; Bartenschlager et al., 1995a). epitope (CYPYDVPDYASL) was purchased from Boeh-
Molecular modeling studies have been used to predict ringer Mannheim (Germany).
determinants of substrate specificity within the NS3 pro-
teinase domain (Pizzi et al., 1994). They suggested that Plasmid constructions
the phenylalanine residue at position 154 of NS3 is a
major determinant shaping the substrate-binding pocket The basic vectors pTM1-2 and pHA and the constructs
pTM1027-1238, pTM1659-1711, and pTM1712-3010 have(SBP) accommodating the P1 residue (the S1-binding
pocket). This assumption was substantiated with a lim- been described previously (Bartenschlager et al., 1995b;
Koch et al., 1996; Fig. 1).ited mutation analysis showing that two distinct substitu-
tions within the putative SBP led to an alteration of NS3 Standard recombinant DNA techniques were used for
construction of all plasmids (Sambrook et al., 1989). Site-substrate specificity (Failla et al., 1996). Very recently,
the three-dimensional structures of the NS3 proteinase directed mutagenesis was done by PCR methodology as
described recently (Bartenschlager et al., 1995b; Koch etdomain (Love et al., 1996) and the proteinase domain
complexed with a synthetic NS4A peptide were deter- al., 1996). In case of mutations of the proteinase, the 642-
nucleotide-long PCR fragments were inserted via NcoImined (Kim et al., 1996). These analyses show that the
SBP is shallow, nonpolar, and determined primarily by and XbaI into pTM1-2 restricted with NcoI and SpeI. In
case of the mutations at the NS4B/5A site, the 718-nucle-residues Leu-135, Phe-154, and Ala-157. It was sug-
gested that Phe-154 forms the bottom of the SBP and otide-long PCR fragments were inserted via HpaI and
EcoRI sites into pTM1712-3010. All subcloned PCR frag-limits the length of the P1 side chain fitting into the S1
pocket. In contrast, the contributions of Leu-135 and Ala- ments were sequenced using IRD-41-labeled primers
and a LiCoR Model 4000 DNA sequencer (Li-CoR, Lin-157 for specificity are less clear.
To further study the role these three residues play coln, NE). Subsequently the complete NS4B-5B frag-
ments were recloned into pHA via the NcoI and SpeIfor NS3 substrate specificity and to determine whether
residues in close proximity might contribute to specificity, restriction sites. The resulting constructs allowed the ex-
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FIG. 1. (A) Alignment of the NS3 region spanning the amino acids around the putative SBP. Sequences corresponding to our HCV isolate (HCV-
G01), HCV isolates of genotypes 1a (HCV-H; Inchauspe et al., 1991), and 1b (HCV-BK; Takamizawa et al., 1991) and the cellular serine-type
proteinases trypsin (TRP), chymotrypsin (CHT), and elastase (ELA) were aligned according to the report of Bazan and Fletterick (1988). The active
site serine residue is marked with a line; amino acids important in shaping the SBP of the cellular proteinases are labeled with an asterisk. Gaps
were inserted to match highly conserved residues. Amino acids selected for site-directed mutagenesis are given underneath with arrows pointing
to the substituting residues. Numbers below the alignment refer to amino acids of NS3 of the G01 isolate (same numbering as HCV-BK) or to the
chymotrypsin numbering (given in parentheses). (B) Detailed view of the NS region of HCV (amino acids 809–3010). Arrows indicate the cleavage
sites for the NS2-3 ( ) and the NS3 ( ) proteinases with numbers above the arrows referring to the corresponding P1 residues. The arrow close
to the end of NS5A ( ) indicates the approximate position of the alternative cleavage site. Sequences expressed with the individual constructs
are drawn below as lines. Numbers beside the lines refer to the first and last amino acids of the expressed sequence and the letters refer to
heterologous amino acids at the amino and carboxy termini of the expressed proteins. The HA epitope is indicated by a box. The nomenclature
for each polypeptide is given to the left.
pression of NS4B-5B polyproteins carrying the HA epi- instructions of the manufacturer. After 3 hr of incubation,
cells were washed twice with methionine-free DMEMtope at their amino termini (Fig. 1).
without FCS, overlaid with DMEM containing 100 mCi/
ml Express protein labeling mixture (NEN Life Science,Trans-cleavage assay using transient expression with
Cologne, Germany), and incubated for 3 hr at 377. Cellsthe vaccinia virus T7 hybrid system and detection of
were washed once with phosphate-buffered saline andcleavage products
lysed in NPB (50 mM Tris–HCl, pH 7.5, 150 mM NaCl,
A total of 7.5 1 104 BHK 21 cells were seeded in a 15- 1% Nonidet-P40, 1% sodium desoxycholate, 0.1% SDS)
mm-diameter dish 20 hr prior to transfection. Cells were supplemented with 1 mM phenylmethylsulfonyl fluoride
infected with the vTF7-3 vaccinia virus at a multiplicity and 0.001 trypsin inhibitor units per milliliter aprotinin
of infection of 5 for 1 hr at room temperature. The inocu- (Sigma, Deisenhofen, Germany). For isolation of HCV-
lum was replaced by DMEM containing 10% FCS and specific proteins by immunoprecipitation (IP), cell lysates
cells were incubated at 377 for 30 min. After washing were cleared by 10 min of centrifugation at 15,000 g and
twice with Optimem (Gibco BRL, Eggenstein, Germany) one-quarter of the supernatant was used for isolation of
a total of 0.35 mg DNA corresponding to a mixture of NS3/4A complexes by IP under nondenaturing conditions
equal amounts of three plasmids was introduced into the (Koch et al., 1996). To reduce the background due to
nonspecific binding of cellular or vaccinia virus proteins,cells using lipofectamine (Gibco BRL) according to the
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IPs were performed with the remainder of the lysate un- at the other, unaltered site could be used as an internal
control for overall enzymatic activity. (iii) NS4B-5B is ader denaturing conditions as described recently (Bar-
tenschlager et al., 1994). Immunocomplexes were ana- long protein, increasing the probability of containing al-
ternative cleavage sites which might be recognized bylyzed by SDS–11% polyacrylamide gel electrophoresis
(PAGE) or, in the case of the NS3/4A complex by SDS – altered NS3 proteinases. Thus, an altered cleavage pat-
tern could be taken as strong evidence for a modificationTricine–11% PAGE. Gels were stained with Coomassie
blue, treated for fluorography with sodium salicylate, and of NS3 substrate specificity. It should be noted that due to
different expression levels and/or stabilities of expressedexposed to Kodak BioMax MR film (Sigma). In some
cases stained gels were directly exposed to BioMax MS proteins and processing products, this experimental sys-
tem gave only qualitative information. Therefore, we didfilms with an intensifying screen (TranScreen, Integra
Biosciences, Fernwald, Germany). Quantifications of HA- not attempt to quantify enzymatic activities of the different
proteins in terms of Km or kcat .4B proteins were done by densitometry scanning and
the amounts of coexpressed NS3 and NS5B proteins To facilitate detection of NS4B, an HA epitope was
fused to the amino terminus (Fig. 1B), allowing immuno-were used as internal controls to correct for transfection
efficiencies. precipitation of NS4B with an HA-specific antiserum. To
reduce the background of cellular or vaccinia virus pro-
teins binding nonspecifically to protein A–Sepharose orRESULTS
immunoglobulin, immunoprecipitations with antisera di-
Experimental strategy
rected against the HA epitope, NS5A or NS5B, were done
under denaturing conditions. Immunoprecipitations withTo identify residues which might contribute to sub-
strate specificity, the amino acid sequence of the HCV the NS3-specific antiserum were done under conditions
allowing the coprecipitation of NS3 proteinase with NS4ANS3 proteinase domain of our isolate (G01) and of two
other isolates corresponding to genotypes 1a and 1b and therefore allowing determination of whether the in-
troduced substitution affected the interaction with the(HCV-H and HCV-BK, respectively) were aligned with the
sequences of well-characterized cellular serine protein- cofactor. The amount of NS3 detected was used to cor-
rect for different expression levels of proteinases ob-ases (trypsin, chymotrypsin, and elastase; Fig. 1A). Fur-
thermore, we included the model described by Pizzi and tained with the individual plasmids.
co-workers (1994) suggesting that Phe-154 is a major
determinant for substrate specificity. Finally, while this Essential role of Phe-154 in substrate specificity
work was in progress, two independent groups reported
the determination of the three-dimensional X-ray crystal The result of an experiment in which all proteinases
were tested for coprecipitation with the NS4A cofactorstructure of the NS3 proteinase (Kim et al., 1996; Love
et al., 1996). They showed that the shape of the SBP is and cleavage of the HA4B-5B substrate is shown in Fig.
2. For the unaltered proteinase (wt, lane 29), the precur-determined primarily by Leu-135, Phe-154, and Ala-157
(chymotrypsin numbering 191, 213, and 216, respectively; sor was almost completely cleaved into HA4B, NS5A,
and NS5B and only very small amounts of unprocessedFig. 1A). Based on this information, we selected several
residues clustered around positions 135 and 154 as tar- HA4B-5B and HA4B-5A intermediates were detected.
Cleavage was specific because no products were foundgets for site-directed mutagenesis. The substitutions
were introduced into a proteinase corresponding to the with an NS3 proteinase in which the active site serine
residue was replaced by alanine (3A, lane 30). For un-first 211 amino acids of NS3 (Fig. 1B). This enzyme, when
coexpressed with the NS4A cofactor, was shown to be known reasons, the NS3 proteinase domain appeared
as a double band. This observation did not correlatefully competent for cleavage at all NS3-dependent sites
(Bartenschlager et al., 1994). Proteinase and cofactor with any of the experimental parameters and was not
reproducible (see Fig. 4).were expressed with the vaccinia virus/T7 hybrid system
in BHK-21 cells together with an NS4B-5B substrate. This As deduced from the increased amounts of HA4B-5B
precursor, which can best be seen in the immunoprecipi-substrate was selected for several reasons: (i) It con-
tained two cleavage sites, an NS4A-dependent site tation with the 5A-specific antiserum, all substitutions
affected cleavage efficiencies to various extents. The(NS4B/5A) and a site at which the NS3 proteinase could
cleave in the absence of cofactor (NS5A/5B) albeit with most drastic effect was found for the 135 L r G and the
152 G r V substitutions which completely inactivated thea low efficiency. Therefore, this substrate allowed us to
determine whether any of the substitutions had a differ- proteinases (lanes 6 and 12). The low expression levels
of enzymes could not account for the lack of precursorential effect on cleavage at these two sites. (ii) Based on
a recent report, we anticipated that the substitutions cleavage because a similarly low expression level was
obtained, e.g., with the 3169H proteinase which was clearlywould not change specificity completely but rather
broaden it (Failla et al., 1996). Since the substrate con- active (lane 20). A less detrimental effect was found for
the 157 A r L and the 157 A r V substitutions (lane 18,tained two cleavage sites it allowed us to determine the
effect of P1 substitutions at one site whereas cleavage 19) whereas the glycine substitution at the same position
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FIG. 2. Substitutions within NS3 and their effects on cleavage activities and specificities. Cells infected with vTF7-3 were transfected with plasmids
directing the expression of NS4A2-54 , the HA4B-5B substrate, and a proteinase specified above each lane. After 3 hr of labeling cells were lysed
and HCV-specific proteins were isolated by immunoprecipitation using antisera (a) directed against NS5B, NS5A, or the HA epitope under denaturing
conditions or, in case of the NS3/4A complex, with an NS3-specific antiserum under native conditions. Proteins were analyzed by SDS–11% PAGE
or by SDS– Tricine–11% PAGE (for the NS3/4A complex) and detected by fluorography. Results obtained with single substitutions are shown on
the left, and those obtained with double substitutions are shown on the right. HCV-specific proteins are identified to the left of the gels. The products
generated by cleavage at the alternative site within NS5A are marked with asterisks. Numbers between the panels refer to the molecular masses
of protein size standards (in kilodaltons). Antisera used for immunoprecipitations are specified to the right. The results obtained with the parental
proteinase (wt) and the mutant in which the active-site serine residue was replaced by an alanine (3A) are shown in lanes 29 and 30, respectively.
had no effect (lane 17), indicating that a small hydropho- an additional site close to the carboxy terminus of NS5A,
removing an approximately 15-kDa fragment from NS5Abic residue at this position is required for full proteolytic
activity. In the case of substitutions of Phe-169 a signifi- or the HA4B-5A precursor (Fig. 1B). Consequently these
proteins were designated 5A* and HA4B-5A*. Since thesecant reduction of cleavage activity was found when a
histidine residue was introduced (lane 20) whereas sub- cleavage products were not produced by the parental
proteinase, this result suggested that the proteinasesstitution by tyrosine had no effect (lane 21), indicating
the requirement for a large hydrophobic (aromatic) amino carrying substitutions of Phe-154 had an altered sub-
strate specificity. Furthermore, the size of the substitutingacid at this position.
The only substitutions for which an altered cleavage residue was important. While the 3154A proteinase be-
haved almost like the parental enzyme (lane 13), intro-pattern was obtained were those affecting the phenylala-
nine residue at position 154. In all cases, in addition to duction of bulkier residues at position 154 increased
cleavage efficiency at the alternative site (3154T and 3154V ;the natural cleavage products, two proteins with appar-
ent molecular weights of approximately 70 and 43 kDa lanes 14 and 15). It should be noted that the same results
were obtained with an NS4B-5B substrate, demonstra-were found (lanes 13–15). While the smaller protein re-
acted only with the 5A-specific antiserum, the 70-kDa ting that the foreign HA sequence at the amino terminus
of NS4B had no effect on cleavage efficiency and sub-protein could be precipitated with both the 5A- and the
HA-specific antisera (not shown). These immune reactivi- strate specificity (not shown). In summary, these data
demonstrate that Phe-154 of the NS3 proteinase is aties and the apparent molecular masses suggested that
the proteins were generated most likely by cleavage at major determinant of substrate specificity.
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FIG. 3. Substrate specificity of proteinases carrying various substitutions of Phe-154. vTF7-3-infected cells were transfected with plasmids allowing
the expression of NS4A2-54 , together with the parental NS3 proteinase (A), or one of the given proteinase mutants (B–D) and HA4B-5B substrates
carrying various substitutions of the P1 residue at the NS4B/5A cleavage site. As a control, all proteinases were also tested for cleavage of the
unaltered substrate (P1-Cys; lane 12 in each panel). At the end of the 3-hr labeling period cells were lysed and after immunoprecipitation with
antisera directed against NS3, NS5B, or the HA epitope, precipitated proteins were analyzed by SDS–PAGE (NS5B and HA4B) or SDS–Tricine–
PAGE (NS3).
To analyze whether the simultaneous substitution of a panel of HA4B-5B substrates in which the P1 cysteine
residue of the NS4B/5A cleavage site was altered (Fig.two residues assumed to be important for substrate
specificity might have a synergistic effect, a panel of 3). We anticipated that an NS3 proteinase with an altered
S1 pocket should accommodate P1 residues which aredouble mutants was generated and tested in the same
way (Fig. 2, right). Focusing on Phe-154, substitutions at not or only very poorly accepted by the parental protein-
ase. Since the processing pattern of NS5A was too com-this position were combined with several other ex-
changes of amino acids which might contribute to speci- plex to allow quantifications, we used the amount of
HA4B produced during a 3-hr labeling period to deter-ficity. As examplified for the 134 Y r S/154 F r V double
mutant, in most cases two substitutions with one affect- mine efficiency of cleavage at the altered site.
In the first set of experiments we analyzed the sub-ing Phe-154 behaved like the single substitution at this
position (compare lane 23 with lane 15). The exception strate specificity of the parental NS31-211 proteinase using
12 substrates, each with a different P1 residue at thewas the double mutation 154 F r T/157 A r L, which
drastically reduced activity (lane 27). The reason for this NS4B/5A junction. As shown in Fig. 3A, only the P1-Cys
(wild type) substrate was cleaved efficiently (lane 12).effect will be described below.
With the exception of the P1-Ala substitution where a
Cleavage activities and substrate specificities of very low cleavage was detected (barely visible on the
proteinases substituted at position 154 film), all other P1-residues were not accepted. This result,
To characterize the substrate specificities of the sub- which agrees with two recent reports (Komoda et al.,
1994; Bartenschlager et al., 1995a), is at variance withstitutions at position 154 more precisely, we generated
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FIG. 4. Comparison of cleavage efficiencies of the parental NS3 proteinase with proteinases carrying threonine, valine, or alanine substitutions
at position 154. Cells were infected with vTF7-3 and transfected with plasmids directing the expression of NS4A2-54 , one of the proteinases given
above the lanes and HA4B-5B substrates in which the P1 residue of the NS4B/5A site was unchanged (lanes 13–16) or replaced by isoleucine
(lanes 1–4), leucine (lanes 5 – 8), or valine (lanes 9–12). HCV-specific proteins are specified on the left side of the gels; antisera used for
immunoprecipitations are specified on the right. All proteins were analyzed by SDS–11% PAGE.
the results described by Kolykhalov and co-workers whereas P1-Leu and P1-Ile were rather good P1 resi-
dues, suggested that we had generated enzymes with(1994) but can be explained by different levels of sensitiv-
ity, different stabilities of the NS4B proteins, or different opened SBPs which interacted most favorably with P1
residues containing large aliphatic side chains.HCV sequences. When the proteinases carrying substitu-
tions of Phe-154 were tested in the same way, a different
Minor roles of residues Leu-135 and Ala-157 inpattern of specificity was found. In all cases, in addition
substrate specificityto the P1-Cys residue, isoleucine, leucine and, to a lesser
extent, valine were accepted as P1 amino acids, demon-
Based on the three-dimensional structure of the NS3strating that the proteinases had an altered substrate
proteinase, it was suggested that the shape of the SBPspecificity and accepted amino acids with large nonpolar
is determined primarily by Leu-135, Phe-154, and Ala-side chains (Figs. 3B–3D, lanes 5, 6, 10, and 12; the
157 (Kim et al., 1996; Love et al., 1996). In the experimentnature of the additional band in the NS3-specific immu-
shown in Fig. 2 we found that substitution of Leu-135noprecipitation shown in Fig. 3C, lane 2, is not known
by phenylalanine had no effect on specificity whereasbut in repetitive experiments it was not reproducible).
substitution by glycine completely blocked cleavage atTo quantify the relative alterations of substrate speci-
the P1-Cys residue. To analyze these enzymes in moreficities of these enzymes, several transfections were per-
detail they were tested for cleavage of all the differentformed in which proteinases with an altered cleavage
HA4B-5B substrates shown in Fig. 3. In case of the 3135Fpattern were compared side by side for processing of
proteinase we found that only P1-Cys was acceptedHA4B-5B substrates carrying P1-Leu, -Ile, -Val, or -Cys
residues at the NS4B/5A junction. As shown in Fig. 4 the
efficiencies with which these P1 residues were accepted TABLE 1
depended on the substituting residue in the S1 pocket.
Cleavage Efficiencies of Altered Proteinases at NS4B/5A SitesUsing densitometry scanning to determine the amount
Carrying Different P1 Residues
of HA4B [corrected for the expression levels of NS3 pro-
teinase and substrate (NS5B)], we found that the 3154A P1
proteinase cleaved at the P1-Cys most efficiently (Table
Proteinase Cys Leu Ile Val1). In the case of the 3154V proteinase, leucine and cys-
teine were accepted equally well whereas the 3154T en- 3154A 100a 61 25 0zyme cleaved at the P1-Leu with the highest efficiency 3154V 100 104 48 21
(Table 1). In summary, for the different proteinases the 3154T 100 124 41 31
3154F 100 0 0 0following orders of affinities for P1 residues were found:
Cys  Leu  Ile  Val for the 154 F r A exchange, Cys
a Relative amount of HA4B produced in the intracellular trans-cleav- Leu  Ile  Val for the 154 F r V substitution, and
age assay during a 3-hr labeling period (given as percentages); values
Leu  Cys  Ile  Val for the F r T exchange (Table were determined by densitometry scanning and they represent mean
1). The fact that P1-Ala was not accepted by these pro- values from three independent experiments ({5%). Cleavage at the P1-
Cys residue was set at 100%.teinases and P1-Val was accepted only very poorly,
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FIG. 5. Influence of Ala-157 on substrate specificity. Proteinases containing either single substitutions of residue 157 or double substitutions of
residues 157 and 154 were coexpressed with NS4A2-54 and HA4B-5B substrates carrying given P1 residues at the NS4B/5A site. As control,
cleavage of the substrates by the parental NS3 proteinase was examined in parallel (lanes 8, 16, and 24). HCV-specific proteins were isolated by
immunoprecipitation using antisera specified to the right and analyzed by SDS–PAGE. Stained gels were dried and exposed to X-ray films using
an intensifying screen.
whereas the 3135G enzyme was completely inactive (not threonine and glycine, respectively, had further altered
specificity toward a proteinase accepting a very bulkyshown), suggesting that Leu-135 plays only a minor role
in specificity and that a large aliphatic residue at this hydrophobic P1 residue, indicating a further opening of
the S1 pocket. A similar alteration of substrate specificityposition is important for proteinase structure.
Thus far we had analyzed the role of Phe-154 and Leu- was described recently (Failla et al., 1996).
135 for substrate specificity. As described above the S1
pocket is formed by these two residues and Ala-157. In DISCUSSION
the experiment shown in Fig. 2 we found that substitu-
tions of this alanine affected only cleavage efficiency, The aim of our study was a better understanding of
the structural determinants of substrate specificity of thenot specificity. However, since Ala-157 is ‘‘covered’’ by
Phe-154, which forms the bottom of the S1 pocket, it was NS3 proteinase. Our finding that Phe-154 is the main
determinant for substrate specificity of the NS3 protein-likely that substitutions at both positions would influence
specificity synergistically and open up the SBP further. ase agrees well with the model of the S1 pocket first
described by Pizzi and co-workers in 1994. The X-rayTherefore, double mutants were generated (3154T/157G ,
3154T/157V , and 3154T/157L) and tested for cleavage of sub- crystal structure of NS3 shows that Phe-154 is located
at the bottom of the S1 pocket, suggesting that this resi-strates with P1 residues with bulky nonpolar side chains
in parallel with the parental NS3 proteinase and the cor- due has a dual function: delimiting the length of the P1
residue that can fit the pocket and establishing a favor-responding single substitutions. As shown in Fig. 5, with
respect to cleavage activity of the P1-Cys substrate, the able interaction between the correct P1 residue cysteine
and the aromatic side chain of the phenylalanine (Fig.enzymes carrying single substitutions of Ala-157 showed
the following order: 3157G 3157A (the parental proteinase) 6A; Burley and Petsko, 1986). This dual function might
be the explanation for the finding that cysteine is the 3157V  3157L (lanes 21, 24, 22, and 23, respectively).
This inverse correlation between size of the substituting most favorable P1 residue (and the only one found at the
trans-cleavage sites). The only other residue for whichresidue and cleavage activity indicated a gradual alter-
ation of the SBP affecting enzyme–substrate interaction. we found cleavage was alanine, but processing effi-
ciency was very low. It is possible that alanine fits theThe analogous correlation was observed when the same
Ala-157 substitutions were combined with the threonine SBP by size but barely interacts with the aromatic ring of
Phe-154. In a recent report Failla and co-workers (1996)substitution of Phe-154 and the double mutants were
tested for cleavage of the P1-Cys substrate (lanes 17–20) described a double mutant in which Phe-154 and Ala-
157 were replaced by threonine and glycine, respectively.or the P1-Leu substrate (lanes 1–4; the small amounts of
HA-4B obtained with the 3154T/157G proteinase were due When tested for cleavage of an NS5A/5B substrate, they
found that the enzyme accepted, in addition to the P1-to low expression levels of this enzyme). In addition, the
3154T/157G enzyme had the broadest substrate specificity Cys, a P1-Phe residue. While this finding agrees with our
results described here for the NS4B/5A site, we per-and could cleave even a P1-Phe substrate (lane 10)
which was not accepted by the parental proteinase (lane formed a more extensive analysis and showed that Ala-
157 plays a minor role in specificity. As we know now16) or any of the other mutants (lanes 9, 11–15). Thus,
the simultaneous substitution of Phe-154 and Ala-157 by from the crystal structure, Phe-154 forms the bottom of
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FIG. 6. Hypothetical model of the SBP of the parental NS3 proteinase (A) and the proteinase carrying a single threonine substitution at position
154 (B). The S1 pocket is indicated with the dotted line and its harbors the P1 side chain of cysteine (A) or leucine (B). The arrow indicates the
bond cleaved by the proteinase. The model shown in (A) is based on suggestions from Pizzi et al. (1994) and Failla et al. (1996) and it includes an
interpretation of the substrate modeling described by Love et al. (1996).
the SBP covering Ala-157 located underneath (Fig. 6A). and valine, indicating that a methyl group attached to the
Cb of the amino acid side chain constitutes a stericConsequently, in agreement with our mutation analysis
alterations of Ala-157 affect specificity only when Phe- hindrance impairing cleavage activity. Although the natu-
ral P1 residue is a cysteine—at least at the trans cleav-154 is also changed (Fig. 6B). This structure also explains
the inverse correlation between an increase in size of age sites—a threonine is also accepted in the context
of the NS3/4A (cis) cleavage site.the amino acid at position 157 and the reduction of effi-
ciency with which substrates with P1 residues of increas- Several studies have identified amino acids determin-
ing substrate specificities of cellular serine proteinases.ing sizes are cleaved. While this model explains the roles
of Phe-154 and Ala-157 for specificity, the function of In the case of trypsin, Ala-157 and Val-167 of HCV NS3
correspond to two glycine residues at positions 216 andLeu-135 is less clear. A drastic change in the size of this
residue (135 L r G) resulted in a completely inactive 226 (chymotrypsin numbering; Fig. 1A). The trypsin–tryp-
sin inhibitor structure suggests that these glycine resi-proteinase whereas a moderate change (135 L r F) did
not impair cleavage activity or specificity, suggesting that dues shape the pocket to accommodate P1 residues with
long side chains. Asp-189 at the bottom of the SBP favorsLeu-135 may play a structural role.
For all serine proteinases, amino acids forming the electrostatic interactions with positively charged amino
acids, explaining the specificity of trypsin for basic P1catalytic triad are found in a particular geometric ar-
rangement in which the serine side chain is hydrogen- residues. The S1-binding sites of trypsin and chymotryp-
sin are nearly identical in structure and primary se-bonded to the histidine imidazole, which in turn is hydro-
gen-bonded to the carboxylate of aspartate (for a review quence (Fig. 1A). However, the aspartic acid at the bot-
tom of the pocket is missing, creating a rather largesee Kraut, 1977). This conformation ensures that the neg-
ative charge on the carboxylate makes the serine oxygen hydrophobic pocket accommodating P1 residues with
large hydrophobic side chains. In this respect, the speci-nucleophilic and in this way reactive toward the sub-
strate. For HCV NS3 the catalytic triad is formed by His- ficity of the NS3154T/157G proteinase was altered toward
the specificity of chymotrypsin. In the case of elastase,57, Asp-81, and Ser-139. However, in the crystal structure
described by Love and co-workers (1996), Asp-81 ap- valine and threonine are found at positions 216 and 226
(Fig. 1A). These bulkier residues narrow the SBP, gener-pears rotated away from His-57 and stabilized by an ion
pair to Arg-155. We found that substitution of Arg-155 by ating a preference for small nonpolar P1 side chains.
From this point of view, elastase most closely resemblesserine had no effect on cleavage efficiency, indicating
that the ion pair is not essential for activity or specificity. the NS3 proteinase at these positions.
Numerous studies analyzed amino acid exchanges inIn fact, as discussed by the authors minor modifications
of structural orientations of amino acids at positions 80 – the context of the different cleavage sites of the polypro-
tein (Kolykhalov et al., 1994; Komoda et al., 1994; Bar-82 bring Asp-81 closer to His-57. This would create a
classic catalytic triad and it was suggested that the posi- tenschlager et al., 1995a) and found differences in the
sensitivities toward P1 substitutions, suggesting that thetional deviation of Asp-81 observed in this structure might
be due to the lack of NS4A or the crystallization process. S1 pocket is not the sole determinant of substrate speci-
ficity. Substrate modeling studies indicate that interactionWe found that all substitutions at position 154 created
enzymes preferring substrates with P1-Cys or P1-Leu of the NS3 proteinase with its substrate is accomplished
by several synergistic factors: (i) specific binding of theresidues. The only amino acids with a branched side
chain for which cleavage was detected were isoleucine P1 residue to the S1 pocket; (ii) stabilization of this bind-
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Bone, R., Silen, J. L., and Agard, D. A. (1989). Structural plasticity broad-ing by a favorable interaction between the aromatic ring
ens the specificity of an engineered protease. Nature 339, 191–195.of Phe-154 and the sulfhydryl group of the P1-Cys or, to
Bordo, D., and Argos, P. (1991). Suggestions for ‘‘safe’’ residue substitu-a lesser extent, the hydroxyl group of threonine; (iii) a tions in site-directed mutagenesis. J. Mol. Biol. 217, 721–729.
continuous P2-P6 main chain interaction; and (iv) a possi- Burley, S. K., and Petsko, G. A. (1986). Amino-aromatic interactions in
ble interaction between the acidic P6 residue of the sub- proteins. FEBS Lett. 203, 139–143.
Cuthbert, J. A. (1994). Hepatitis C: Progress and problems. Clin. Micro-strate and Arg-161 or Lys-165 (Pizzi et al., 1994; Kim et
biol. Rev. 7, 505–532.al., 1996; Love et al., 1996). In agreement with these
Dubuisson, J., Hsu, H. H., Cheung, R. C., Greenberg, H. B., Russell,results Urbani and co-workers (1997) provided evidence
D. G., and Rice, C. M. (1994). Formation and intracellular localization
that ground state binding of the substrate is achieved by of hepatitis C virus envelope glycoprotein complexes expressed by
multiple interactions involving distal residues whereas recombinant vaccinia and sindbis viruses. J. Virol. 68, 6147–6160.
the P1 residue is the primary determinant of efficiency Eckart, M. R., Selby, M., Masiarz, F., Lee, C., Berger, K., Crawford, C.,
Kuo, C., Kuo, G., Houghton, M., and Choo, Q.-L. (1993). The hepatitiswith which the bound substrate will proceed through the
C virus encodes a serin proteinase involved in processing of thetransition state. In this respect the S1 pocket appears to
putative nonstructural proteins from the viral polyprotein precursor.be a primary determinant for catalysis. Biochem. Biophys. Res. Commun. 192, 399–406.
In summary we have analyzed the different contribu- Failla, C., Tomei, L., and De Francesco, R. (1995). An amino-terminal
tions the residues forming the SBP have for specificity domain of the hepatitis C virus NS3 protease is essential for interac-
tion with NS4A. J. Virol. 69, 1769–1777.and activity. In agreement with other reports describing
Failla, C. M., Pizzi, E., De Francesco, R., and Tramontano, A. (1996).the alteration of substrate specificity of proteinases by
Redesigning the substrate specificity of hepatitis C virus NS3 protein-distinct amino acid substitutions (e.g., Bone et al., 1989;
ase. Folding Design 1, 35–42.
Hedstrom et al., 1992; Failla et al., 1996), we found that Failla, C., Tomei, L., and De Francesco, R. (1994). Both NS3 and NS4A
specificity can be restricted to a few determinants within are required for proteolytic processing of hepatitis C virus nonstruc-
tural proteins. J. Virol. 68, 3753–3760.the enzyme. However, given the elaborate interactions
Fuerst, T. R., Niles, E. G., Studier, F. W., and Moss, B. (1986). Eucaryoticbetween the NS3 proteinase and the residues around
transient-expression system based on recombinant vaccinia virusthe scissile bonds, further studies will be required to
that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad.elucidate how fine specificity of the enzyme is brought
Sci. USA 83, 8122–8126.
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